Breast Cancer: Platinum Based Chemotherapy or Capecitabine in Treating Patients With
Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
What are the good and bad effects of getting more treatment with capecitabine (i.e.
one of the usual approaches) compared to getting more treatment with a platinum-based
chemotherapy (cisplatin or carboplatin) after surgery?
Basic Study Information
Purpose:Location: Cancer Center
If you participate in this study, you will be randomized to either receive platinum-based
chemotherapy for 12 weeks (you and your doctor will choose between cisplatin or carboplatin)
or you will get the usual approach used for this type of cancer, capecitabine for
Study Web URL: https://clinicaltrials.gov/ct2/show/NCT02445391?term=ea1131&rank=1
Study Reference #: CBRS17061
Lead Researcher (Principal Investigator)
Lead Researcher: Michelle Shayne, MD
Study Contact InformationStudy Coordinator: Kate Corcoran
Phone: (585) 275-7771
Additional Study Details
Learn More About These Conditions
More information about Breast Cancer
Trial Not Found
The study you are looking for is not active at this time.
Return to Search